2022
International patterns and trends of childhood and adolescent cancer, 1978-2012
Zhao Y, Sun P, Xiao J, Jin L, Ma N, Li Z, Feng G, Huang H, Deziel N, Ma X, Ni X, Zhang Y. International patterns and trends of childhood and adolescent cancer, 1978-2012. Journal Of The National Cancer Center 2022, 2: 78-89. PMID: 39034956, PMCID: PMC11256536, DOI: 10.1016/j.jncc.2022.02.001.Peer-Reviewed Original ResearchCancer incidence ratesIncidence rateCancer incidenceMalignant central nervous system tumorsCentral nervous system tumorsOverall childhood cancerIncidence of lymphomaNervous system tumorsLeukemia incidence ratesSystem tumorsTesticular cancerChildhood cancerThyroid cancerAdolescent cancerKidney cancerJoinpoint regressionCancer incidentsAge groupsCancerCancer typesIncidenceTemporal trendsMethods DataAdolescentsChildren
2021
Analysis of Survival Among Adults With Early-Onset Colorectal Cancer in the National Cancer Database
Cheng E, Blackburn HN, Ng K, Spiegelman D, Irwin ML, Ma X, Gross CP, Tabung FK, Giovannucci EL, Kunz PL, Llor X, Billingsley K, Meyerhardt JA, Ahuja N, Fuchs CS. Analysis of Survival Among Adults With Early-Onset Colorectal Cancer in the National Cancer Database. JAMA Network Open 2021, 4: e2112539. PMID: 34132794, PMCID: PMC8209612, DOI: 10.1001/jamanetworkopen.2021.12539.Peer-Reviewed Original ResearchConceptsEarly-onset colorectal cancerOnset colorectal cancerNational Cancer DatabaseColorectal cancerAge 51Overall survivalCancer DatabaseIncidence of CRCCox proportional hazards regressionPrimary colorectal cancerKaplan-Meier analysisProportional hazards regressionAge 50 yearsAge 25 yearsAnalysis of survivalCohort studySurvival benefitHazards regressionUnadjusted analysesCancer incidenceMAIN OUTCOMEAge 35Survival advantageLower riskStage I
2020
Birth Characteristics and Risk of Early-Onset Synovial Sarcoma
Wiemels JL, Wang R, Feng Q, Clark CJ, Amatruda JF, Rubin E, Yee AC, Morimoto LM, Metayer C, Ma X. Birth Characteristics and Risk of Early-Onset Synovial Sarcoma. Cancer Epidemiology Biomarkers & Prevention 2020, 29: 1162-1167. PMID: 32245786, PMCID: PMC7605594, DOI: 10.1158/1055-9965.epi-20-0093.Peer-Reviewed Original ResearchConceptsSynovial sarcomaBirth weightMultivariable logistic regression analysisEpidemiologic researchFurther epidemiologic researchLittle epidemiologic researchHigh birth weightSynovial sarcoma casesSiblings of patientsLogistic regression analysisBirth orderNon-Hispanic whitesYoung adult periodYear of birthElevated cancer incidencePoor outcomeBirth characteristicsPeak incidenceRare cancersRisk factorsCancer incidenceCancer casesAggressive cancerHigh riskSarcoma cases
2015
Organophosphate insecticide use and cancer incidence among spouses of pesticide applicators in the Agricultural Health Study
Lerro CC, Koutros S, Andreotti G, Friesen MC, Alavanja MC, Blair A, Hoppin JA, Sandler DP, Lubin JH, Ma X, Zhang Y, Freeman L. Organophosphate insecticide use and cancer incidence among spouses of pesticide applicators in the Agricultural Health Study. Occupational And Environmental Medicine 2015, 72: 736. PMID: 26150671, PMCID: PMC4909328, DOI: 10.1136/oemed-2014-102798.Peer-Reviewed Original ResearchConceptsCancer incidenceRelative riskCancer riskPesticide applicatorsAgricultural Health Study cohortOP useHealth Study cohortAgricultural Health StudyNon-Hodgkin lymphomaReproductive health historyStudy cohortPotential confoundersOvarian cancerThyroid cancerBreast cancerElevated riskEpidemiological studiesHealth StudyHealth historyPoisson regressionMale populationCancerFurther evaluationDemographic informationSpecific organophosphatesUse of acetochlor and cancer incidence in the Agricultural Health Study
Lerro CC, Koutros S, Andreotti G, Hines CJ, Blair A, Lubin J, Ma X, Zhang Y, Beane Freeman L. Use of acetochlor and cancer incidence in the Agricultural Health Study. International Journal Of Cancer 2015, 137: 1167-1175. PMID: 25559664, PMCID: PMC4492894, DOI: 10.1002/ijc.29416.Peer-Reviewed Original ResearchConceptsAgricultural Health StudyLung cancerPancreatic cancerCancer incidenceRelative riskHealth StudyColorectal cancer riskExposure-response trendsAdditional potential confoundersRisk of melanomaTime of interviewIncident cancerColorectal cancerPotential confoundersEpidemiologic studiesCancer riskPoisson regressionCancerTelephone interviewsPesticide applicatorsDefinitive conclusionsConfidence intervalsRiskMelanomaIncidence
2013
The Cost of Breast Cancer Screening in the Medicare Population
Gross CP, Long JB, Ross JS, Abu-Khalaf MM, Wang R, Killelea BK, Gold HT, Chagpar AB, Ma X. The Cost of Breast Cancer Screening in the Medicare Population. JAMA Internal Medicine 2013, 173: 220-226. PMID: 23303200, PMCID: PMC3638736, DOI: 10.1001/jamainternmed.2013.1397.Peer-Reviewed Original ResearchConceptsBreast cancer screeningCancer screeningTreatment costsBetter breast cancer outcomesEnd Results-Medicare databaseService MedicareHigh screening costsWomen ages 66Breast cancer outcomesInitial cancer treatmentHospital referral region levelWomen 75 yearsInitial treatment costsEarly-stage cancerDigital screening mammographyCancer outcomesCancer incidenceCancer stageLowest quartileAge 66Breast cancerOlder womenMedicare populationComputer-aided detectionTreatment expenditures
2008
Heterocyclic aromatic amine pesticide use and human cancer risk: Results from the U.S. Agricultural Health Study
Koutros S, Lynch CF, Ma X, Lee WJ, Hoppin JA, Christensen CH, Andreotti G, Freeman LB, Rusiecki JA, Hou L, Sandler DP, Alavanja MC. Heterocyclic aromatic amine pesticide use and human cancer risk: Results from the U.S. Agricultural Health Study. International Journal Of Cancer 2008, 124: 1206-1212. PMID: 19058219, PMCID: PMC2904521, DOI: 10.1002/ijc.24020.Peer-Reviewed Original ResearchConceptsAgricultural Health StudyColon cancerPesticide applicatorsBladder cancerCancer incidenceHealth StudyIntensity-weighted lifetime exposure daysEtiology of bladderLifetime exposure daysRate ratioLicensed pesticide applicatorsPoisson regression analysisHuman cancer riskProximal cancersIncident cancerProspective cohortLymphohematopoietic cancersExcess riskCancer riskExposure daysLifetime exposureCancerRegression analysisRiskHeterocyclic aromatic amines